Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deniz Kirik

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Biochimica Et Biophysica Acta|March 4, 2009
Scientific rationale for the development of gene therapy strategies for Parkinson's diseaseTomas Björklund, Deniz Kirik
Science (New York, N.Y.)|November 21, 2015
A doctor's dilemmaDeniz Kirik, Elisabeth Pain
Brain : a Journal of Neurology|June 28, 2005
Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising resultsDeniz Kirik, Anders Björklund
Therapeutic Delivery|July 27, 2012
Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson's diseaseAyse Ulusoy, Deniz Kirik
The Journal of Clinical Investigation|June 18, 2014
Twisting mice move the dystonia field forwardAsa Petersén, Deniz Kirik
Trends in Neurosciences|July 10, 2003
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectorsDeniz Kirik, Anders Björklund
Experimental Neurology|June 10, 2008
Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?Ayse Ulusoy, Deniz Kirik
Neurobiology of Disease|July 31, 2012
Introduction: gene therapy has gone from a pipe dream to clinical realityJeffrey H Kordower, Deniz Kirik
Neuro-Degenerative Diseases|June 13, 2009
Huntington's disease - new perspectives based on neuroendocrine changes in rodent modelsAsa Petersén, Sofia Hult, Deniz Kirik
Nature Neuroscience|January 30, 2004
Localized striatal delivery of GDNF as a treatment for Parkinson diseaseDeniz Kirik, Biljana Georgievska, Anders Björklund
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Biochimica Et Biophysica Acta|March 4, 2009
Scientific rationale for the development of gene therapy strategies for Parkinson's diseaseTomas Björklund, Deniz Kirik
Science (New York, N.Y.)|November 21, 2015
A doctor's dilemmaDeniz Kirik, Elisabeth Pain
Brain : a Journal of Neurology|June 28, 2005
Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising resultsDeniz Kirik, Anders Björklund
Therapeutic Delivery|July 27, 2012
Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson's diseaseAyse Ulusoy, Deniz Kirik
The Journal of Clinical Investigation|June 18, 2014
Twisting mice move the dystonia field forwardAsa Petersén, Deniz Kirik
Trends in Neurosciences|July 10, 2003
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectorsDeniz Kirik, Anders Björklund
Experimental Neurology|June 10, 2008
Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?Ayse Ulusoy, Deniz Kirik
Neurobiology of Disease|July 31, 2012
Introduction: gene therapy has gone from a pipe dream to clinical realityJeffrey H Kordower, Deniz Kirik
Neuro-Degenerative Diseases|June 13, 2009
Huntington's disease - new perspectives based on neuroendocrine changes in rodent modelsAsa Petersén, Sofia Hult, Deniz Kirik
Nature Neuroscience|January 30, 2004
Localized striatal delivery of GDNF as a treatment for Parkinson diseaseDeniz Kirik, Biljana Georgievska, Anders Björklund
Pageof 15